4.7 Article

Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4?- piperidin]-1?-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of ? Receptors via Fluorescence-Based Techniques

Related references

Note: Only part of the references are listed.
Article Chemistry, Medicinal

Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect

Francesca S. Abatematteo et al.

Summary: The sigma-1 receptor is important in physiological and pathological processes, and the phenoxyalkylpiperidine compounds show potential as high-affinity agonists. Compound 1a, in particular, exhibits strong activity and warrants further investigation.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Oncology

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

Pratibha S. Binder et al.

Summary: The study found that combining SW IV-134 with cisplatin chemotherapy had better treatment outcomes for ovarian cancer. The combination therapy showed significantly higher anti-tumor efficacy in cell experiments and mouse models, with a higher tumor regression rate. Therefore, the combination of SW IV-134 and cisplatin chemotherapy has great potential as a treatment option for patients with advanced ovarian cancer.

BMC CANCER (2022)

Article Biochemistry & Molecular Biology

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4

Dario P. Anobile et al.

Summary: A new sigma-2 receptor ligand FA4 was synthesized and evaluated for its anti-proliferative, pro-apoptotic, and anti-migratory activity on PDAC primary cell cultures. The results showed that FA4 effectively inhibited the aggressive and chemoresistant behavior of PDAC, with significant antiproliferative and antimigratory effects.

MOLECULES (2022)

Article Biochemistry & Molecular Biology

Alzheimer's protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

Colleen S. Limegrover et al.

Summary: The A673T mutation confers significant differences in the formation of oligomers, impact on cellular vesicle trafficking rate, and binding affinity to synaptic receptors compared to wild type protein. Mutant protein has lower toxicity and may provide a protective mechanism against Alzheimer's disease through its reduced binding affinity to synaptic receptors. Therapeutics targeting oligomer binding to synapses may be beneficial in AD.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Multidisciplinary Sciences

Structures of the σ2, receptor enable docking for bioactive ligand discovery

Assaf Alon et al.

Summary: The study determined the crystal structure of sigma(2) receptor with roluperidone and PB28, identified new chemical compounds with higher affinities, and confirmed the role of sigma(2) receptor in pain perception, highlighting the potential for developing new pain treatments.

NATURE (2021)

Article Oncology

Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models

Mauro Niso et al.

Summary: The novel sigma-2 receptor targeting thiosemicarbazone, FA4, showed more potent cytotoxicity in pancreatic cancer cells compared to previously studied thiosemicarbazones (MLP44, PS3, ACthio-1). It activated pro-apoptotic pathways and decreased autophagy, holding promise for developing more efficient therapies targeting specific characteristics of individual tumor types.

CELLULAR ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

Pridopidine reduces mutant huntingtin-induced endoplasmic reticulum stress by modulation of the Sigma-1 receptor

Marina Shenkman et al.

Summary: Pridopidine can significantly alleviate mHtt-induced ER stress, reduce markers of the three UPR branches with the strongest effect on the PERK branch. This effect is S1R-dependent and may be achieved by increasing insoluble S1R and stabilizing activated S1R oligomers.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Microbiology

Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells

David A. Ostrov et al.

Summary: The study identified sigma receptor ligands with agonism of the sigma-1 receptor, ligation of the sigma-2 receptor, and a combination of the two pathways as effective in inhibiting SARS-CoV-2 infection, offering a potential therapeutic avenue for COVID-19 prevention and treatment in primate and human cells.

PATHOGENS (2021)

Article Clinical Neurology

The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models

Luana Naia et al.

Summary: Pridopidine is a selective Sigma-1 receptor agonist being developed for Huntington disease and amyotrophic lateral sclerosis. It enhances mitochondrial function by improving activity, elongation, and motility, leading to neuroprotective effects in HD models. Pridopidine also reduces ROS levels and restores antioxidant response in various HD models, showing potential therapeutic benefits.

NEUROTHERAPEUTICS (2021)

Article Pharmacology & Pharmacy

Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity

Cheri Z. Liu et al.

Summary: The Sigma-2 receptor is upregulated in cancer cells compared to normal cells, and traditional Sigma-2 receptor agonists can induce apoptosis and autophagy, with recent research suggesting a metabolic stimulative function as well. This study compared the activities of two related compounds, CM571 and MAM03055A, showing that CM571 induces metabolic stimulation while MAM03055A potently induces cell death in various cancer cell lines by binding preferentially to sigma-2 receptors. Additionally, MAM03055A exhibited pseudo-irreversible binding to sigma-2 receptors and caused a time-dependent loss of the receptor protein from cells, indicating divergent effects compared to CM571.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives

Francesca Serena Abatematteo et al.

Summary: The sigma-1 receptor is a pluripotent chaperone protein that interacts with several client proteins at the mitochondria-endoplasmic reticulum membrane interfaces. Developing multifunctional ligands targeting sigma-1 receptors may be a successful strategy in overcoming pharmacokinetic issues associated with the administration of diverse drugs. The evidence of unintentional binding between some clinically used drugs and sigma-1 protein supports the potential of targeting sigma-1 receptors with MTDLs for the treatment of multifactorial pathologies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant 18F-Labelled σ2 Receptor Ligand

Rares-Petru Moldovan et al.

Summary: The sigma(2) receptor plays a crucial role in cholesterol homeostasis and neoplastic processes, driving research in the field of cancer diagnosis and therapy. RM273, a novel sigma(2) receptor ligand labeled with F-18, shows promising penetration into the brain and potential for detecting receptor upregulation in cancer cells. The developed radioligand has the potential for non-invasive molecular imaging to assess the correlation between sigma(2) receptor availability and properties of brain tumors.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Defending Antiviral Cationic Amphiphilic Drugs That May Cause Drug-Induced Phospholipidosis

Thomas R. Lane et al.

Summary: While a recent publication suggested that cationic amphiphilic drugs repurposed for COVID-19 may not be effective in vivo, additional experimental data supports the efficacy of many of these molecules both in vitro and in vivo without causing phospholipidosis. Therefore, further exploration of this class of compounds is warranted in the search for broad spectrum antivirals.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Medicinal

Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study

Teresa Maria Creanza et al.

Summary: The study introduces structure-based classifiers able to distinguish hERG binders from nonbinders, providing a valuable tool for predicting hERG-related cardiotoxicity.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Medicinal

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective

Antonino N. Fallica et al.

Summary: Sigma receptors have been found to play a significant role in cancer growth and cell proliferation. Recent research focuses on developing selective sigma receptor ligands with potential anti-tumor properties. Studies in medicinal chemistry provide insights into the structure-activity relationships of selective sigma receptor ligands.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

σ2 Receptor and Its Role in Cancer with Focus on a MultiTarget Directed Ligand (MTDL) Approach

Francesca Serena Abatematteo et al.

Summary: The sigma(2) receptor has potential in cancer diagnosis and therapy, and MultiTarget Directed Ligands (MTDLs) show promise in overcoming pharmacokinetic issues associated with multiple drug administration.

MOLECULES (2021)

Article Multidisciplinary Sciences

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A. Tummino et al.

Summary: Phospholipidosis may be a shared mechanism underlying the antiviral activity of many repurposed drugs, and early detection and elimination of these effects can enable a focus on molecules with therapeutic potential.

SCIENCE (2021)

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Article Chemistry, Multidisciplinary

Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease

Pietro Delre et al.

FRONTIERS IN CHEMISTRY (2020)

Article Neurosciences

Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study

Andrew McGarry et al.

JOURNAL OF HUNTINGTONS DISEASE (2020)

Review Pharmacology & Pharmacy

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?

Jose Miguel Vela

FRONTIERS IN PHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

The Molecular Function of σ Receptors: Past, Present, and Future

Hayden R. Schmidt et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Article Chemistry, Medicinal

High-affinity sigma-1 (σ1) receptor ligands based on the σ1 antagonist PB212

Mauro Niso et al.

FUTURE MEDICINAL CHEMISTRY (2019)

Article Medicine, Research & Experimental

Quantum Dot Based Luminescent Nanoprobes for Sigma-2 Receptor Imaging

Maria Laura Pati et al.

MOLECULAR PHARMACEUTICS (2018)

Article Biochemistry & Molecular Biology

Structural basis for σ1 receptor ligand recognition

Hayden R. Schmidt et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Article Multidisciplinary Sciences

Identification of the gene that codes for the σ2 receptor

Assaf Alon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Chemistry, Medicinal

Development of sigma-1 (σ1) receptor fluorescent ligands as versatile tools to study σ1 receptors

Carmen Abate et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Multidisciplinary Sciences

Crystal structure of the human σ1 receptor

Hayden R. Schmidt et al.

NATURE (2016)

Article Pharmacology & Pharmacy

Elements in support of the 'non-identity' of the PGRMC1 protein with the σ2 receptor

Carmen Abate et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2015)

Review Pharmacology & Pharmacy

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

Samuel Genheden et al.

EXPERT OPINION ON DRUG DISCOVERY (2015)

Article Chemistry, Medicinal

The σ2 Receptor: A Novel Protein for the Imaging and Treatment of Cancer

Robert H. Mach et al.

JOURNAL OF MEDICINAL CHEMISTRY (2013)

Article Chemistry, Medicinal

2-Aminopyridine Derivatives as Potential s2 Receptor Antagonists

Carmen Abate et al.

CHEMMEDCHEM (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Sigma-2 Receptor as Potential Indicator of Stem Cell Differentiation

Jodi L. Haller et al.

MOLECULAR IMAGING AND BIOLOGY (2012)

Article Clinical Neurology

A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis

Amr Al-Saif et al.

ANNALS OF NEUROLOGY (2011)

Article Multidisciplinary Sciences

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site

Jinbin Xu et al.

NATURE COMMUNICATIONS (2011)

Article Biochemical Research Methods

Synthesis of anhydride precursors of the environment-sensitive fluorophores 4-DMAP and 6-DMN

Matthieu Sainlos et al.

NATURE PROTOCOLS (2007)

Review Chemistry, Multidisciplinary

Integrated modeling program, applied chemical theory (IMPACT)

JL Banks et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)